Related Experiment Video
Updated: Apr 10, 2026
08:18
Preparation of Naringenin Solution for In Vivo Application
Published on: August 10, 2021
4.0K
[Effect of naringin on osteoclast differentiation]
Summary
Naringin from Drynariae Rhizoma effectively inhibits osteoclast formation, proliferation, and bone resorption. This study reveals its potential mechanism involves regulating key gene expressions during osteoclast differentiation.
Area of Science:
- Pharmacology
- Cell Biology
- Biochemistry
Background:
- Osteoclasts are crucial for bone remodeling.
- Dysfunctional osteoclasts contribute to bone diseases.
- Drynariae Rhizoma is a traditional herbal medicine.
Purpose of the Study:
- To investigate the inhibitory effects of naringin on osteoclastogenesis.
- To elucidate the molecular mechanisms underlying naringin's action.
Main Methods:
- Osteoclast differentiation induced in RAW264.7 cells using RANKL.
- Assessed osteoclast formation, bone resorption, and proliferation.
- Analyzed gene expression of RANK, TRAP, MMP-9, NFATc1, and C-fos via RT-PCR.
Main Results:
- Naringin significantly inhibited osteoclast differentiation, bone resorption, and proliferation.
- Down-regulated mRNA expression of RANK, TRAP, MMP-9, and NFATc1.
- Up-regulated C-fos mRNA expression.
Conclusions:
- Naringin exhibits potent anti-osteoclastogenic activity.
- Mechanism involves modulating specific gene expressions during osteoclast differentiation.
- Naringin shows therapeutic potential for bone-resorptive diseases.
